paroxetine, Paxil, Paxil CR, Pexeva
Title: paroxetine, Paxil, Paxil CR, PexevaCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/7/2013 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 7, 2013 Category: Drugs & Pharmacology Source Type: news
Will OCD Medication Work for Me?
Although treatment of OCD symptoms with OCD medication such as Prozac (Fluoxetine), Zoloft (Sertraline) and Paxil (Paroxetine) or the tricyclic antidepressant Anafranil (Clomipramine) can be effective, not everyone responds to OCD medication. Let’s explore the factors that predict whether you’ll respond to OCD medication. (Source: About.com Obsessive Compulsive Disorder)
Source: About.com Obsessive Compulsive Disorder - June 5, 2013 Category: Psychiatry Tags: health Source Type: news
Remeron/mirtazapine Effective, Safe for Senior...
A multicenter, phase-IV clinical trial headed by a Stanford University Medical Center professor has shown that an antidepressant known as mirtazapine works significantly faster, is more effective and causes fewer adverse side effects in elderly patients than does paroxetine, another commonly prescribed antidepressant. The research is the first direct comparison of the two drugs in treating elderly people suffering from a major depressive illness. (Source: About.com Mental Health)
Source: About.com Mental Health - June 5, 2013 Category: Psychiatry Tags: health Source Type: news
Paxil approved for Generalized Anxiety Disorder
Paxil (paroxetine) is an antidepressant medication in the same class as Prozac and Zoloft. It is also used to treat generalized anxiety disorder. (Source: About.com Mental Health)
Source: About.com Mental Health - June 5, 2013 Category: Psychiatry Authors: mentalhealth.guide at about.com Tags: health Source Type: news
paroxetine, Paxil, Paxil CR, Pexeva
Title: paroxetine, Paxil, Paxil CR, PexevaCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/31/2013 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - May 31, 2013 Category: Psychiatry Source Type: news
Meds Don't Help Anymore
Tortoiseshell on our forum asked the following question:
I feel it is time for me to change meds or add something to the current meds.
I am currently on Pristiq 100mg/day and Lamictal 200 mg/day. Increasing the dose didn't help, but worsened the side effects. These meds worked relatively well for me for 3 years until last September I had very emotionally difficult situation and got into destructive relationship. It threw me back again. Since then I haven't been able to enjoy myself and life despite of going to counseling weekly. Just not getting better.
I am seeing my psychiatrist next week. She is very flexi...
Source: About.com Depression - May 30, 2013 Category: Psychiatry Source Type: news
Paxil and Birth Defects
The US Food and Drug Administration today released an alert regarding use of the SSRI antidepressant Paxil (generic Paroxetine) by pregnant women. Two studies indicate that there is a substantially greater risk of birth defects when Paxil is used during the first three months of pregnancy. (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - May 25, 2013 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news
SSRIs (incl. Paxil) May Increase Risk of Complications after Surgery:...
As Time published on April 30, a new study revealed that selective serotonin reuptake inhibitors (SSRIs), including Paxil, are linked to higher risk of complications after surgery. In light of this...(PRWeb May 24, 2013)Read the full story at http://www.prweb.com/releases/2013/5/prweb10765450.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 25, 2013 Category: Pharmaceuticals Source Type: news
Breast cancer in the under 50s tops 10,000 a year
Incidence rates in younger women rise by 11%Related items from OnMedicaResearchers identify drug target for metastasisBreast screening risks outweigh benefits says BaumPersonalised medicine one step closerMortality higher if using paroxetine and tamoxifenResearchers find clues to breast cancer survival (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 3, 2013 Category: UK Health Source Type: news
GSK statement in response to OFT Statement of Objections
GSK supports fair competition and we very strongly believe that we acted within the law, as the holder of valid patents for paroxetine, in entering the agreements under investigation. (Source: GSK news)
Source: GSK news - April 19, 2013 Category: Pharmaceuticals Source Type: news
Paroxetine as Inhibitor of Diabetic Endothelial DysfunctionParoxetine as Inhibitor of Diabetic Endothelial Dysfunction
Can this antidepressant reduce cardiovascular risk associated with diabetes? Diabetes (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Notice of Removal to Federal Courthouse for Paxil Birth Defects...
According to court documents, on February 14th, 2013, lawyers representing GlaxoSmithKline filed a notice of removal to federal courthouse for a Paxil birth defects lawsuit. In light of these news,...(PRWeb February 20, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10444994.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 21, 2013 Category: Pharmaceuticals Source Type: news
NHS Evidence expert commentary: Citalopram for the treatment of depression
Source: NHS Evidence
Area: News
The February edition of 'Eyes on Evidence', the free monthly e-bulletin from NHS Evidence covering major new published evidence as it emerges with an explanation about what it means for current practice, includes an expert commentary on new data from a Cochrane review of 37 RCTs which assessed the efficacy, acceptability and tolerability of citalopram compared with other antidepressants in the acute-phase treatment of major depression in over 6000 patients.
Citalopram did not differ from most antidepressants in the primary outcome, the number of patients who responded to treatmen...
Source: NeLM - Mental Health - February 14, 2013 Category: Psychiatry Source Type: news
Families face battle with GSK over dangerous diabetes drug
Exclusive: Pharmaceutical giant resists claims despite settlement with victims in USThousands of families in the UK could be deprived of compensation for the death or harm of a relative caused by the diabetes drug Avandia, even though the British maker has agreed to pay billions of dollars to settle similar claims in the US.The licence for Avandia was revoked in Europe, in September 2010, because of evidence that it could cause heart failure and heart attacks. The drug can still be prescribed in the US, but not to patients at risk of heart problems.A scientist with the Food and Drug Administration estimated that Avandia co...
Source: Guardian Unlimited Science - January 29, 2013 Category: Science Authors: Sarah Boseley Tags: The Guardian United States World news Pharmaceuticals industry Medical research Legal aid Law UK news Diabetes GlaxoSmithKline Business Source Type: news
Researchers identify drug target for metastasis
Breakthrough made in how breast cancer spreadsRelated items from OnMedicaNICE updates lung cancer guidanceBlood test could help predict breast cancer survivalBreast screening risks outweigh benefits says BaumCancer diagnosis slow in women, young and non-whitesMortality higher if using paroxetine and tamoxifen (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 28, 2013 Category: UK Health Source Type: news
